WeVote
Log In

Bill

Bill

S 7166

Authorizes the presence of epinephrine auto-injector devices on pre-school premises

2025 Regular Session Introduced by Brad Hoylman-Sigal

Bill S 7166 allows preschools to keep epinephrine auto-injectors on-site, ensuring quick access to life-saving treatment for children at risk of severe allergic reactions.

REFERRED TO HEALTH
0
WeVote Research Nonpartisan
Bill Summary · S 7166

Summary of Bill S 7166

Bill Information

  • Bill Number: S 7166
  • Title: Authorizes the presence of epinephrine auto-injector devices on pre-school premises
  • Status: Referred to Health Committee
  • Introduced: April 3, 2025
  • Classification: Legislative Bill

Purpose and Intent

Bill S 7166 aims to enhance the safety of preschool environments by allowing the presence of epinephrine auto-injector devices on their premises. This legislation is particularly focused on protecting children who may be at risk of severe allergic reactions, known as anaphylaxis, which can occur due to various allergens.

Key Provisions

  • Authorization of Devices: The bill permits preschools to maintain epinephrine auto-injectors on-site. This is intended to ensure immediate access to life-saving medication in the event of an allergic reaction.
  • Regulatory Compliance: Preschools will be required to comply with specific guidelines regarding the storage, maintenance, and administration of these devices, although the exact details of these guidelines are not specified in the current version of the bill.
  • Training Requirements: The bill may include provisions for training staff on the proper use of epinephrine auto-injectors, ensuring that personnel are prepared to respond effectively in emergencies.

Impact

  • Affected Parties: This bill primarily impacts preschool facilities, staff, and the children enrolled in these programs, particularly those with known allergies.
  • Health and Safety: By allowing the presence of epinephrine auto-injectors, the bill aims to reduce the risk of fatalities or severe health complications arising from allergic reactions among preschool-aged children.

Procedural Aspects

  • Current Status: As of the introduction date, the bill has been referred to the Health Committee for further consideration. The timeline for subsequent actions, such as hearings or votes, has not yet been established.
  • Related Legislation: This bill is related to several prior-session bills (S 38, S 5019, S 280, S 4310, S 723, S 3229) and has a companion bill in the Assembly (A 645), indicating ongoing legislative interest in this area.

Conclusion

Bill S 7166 represents a proactive approach to safeguarding the health of young children in preschool settings by facilitating access to emergency medical treatment for allergic reactions. Its successful passage could lead to improved health outcomes for children with allergies and greater peace of mind for parents and caregivers.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.